NCT03745053View on ClinicalTrials.gov

XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

February 5, 2019

Primary Completion Date

September 2, 2023

Study Completion Date

September 2, 2023

Conditions
Coronary Artery Disease
Interventions
DEVICE

Xlimus DES Implantation during coronary angioplasty

Xlimus DES Implantation during coronary angioplasty

DEVICE

Synergy DES Implantation during coronary angioplasty

Synergy DES Implantation during coronary angioplasty

Trial Locations (4)

20097

IRCCS Policlinico S. Donato, San Donato Milanese

28046

Hospital La Paz, Madrid

08025

Hospital Bellvitge, Barcelona

Hospital de la Santa Creu i Sant Pau, Barcelona

Sponsors
All Listed Sponsors
collaborator

Mediolanum Cardio Research

OTHER

lead

Cardionovum GmbH

INDUSTRY

NCT03745053 - XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization | Biotech Hunter | Biotech Hunter